Phase
Condition
N/ATreatment
Tranexamic Acid
Tranexamic Acid (TXA)
Clinical Study ID
Ages 18-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Either sex
age 18-65 years
ASA I-II who are listed for elective functional endoscopic sinus surgery (FESS)under general anesthesia
normal accepted coagulation profile and hematocrit value ≥30
Exclusion
Exclusion Criteria:
• chronic renal failure
liver cirrhosis
bleeding disorders
current anticoagulant therapy
pregnancy or breastfeeding
impaired color vision
severe vascular ischemia
history of venous thrombosis, pulmonary embolism
long term treatment with acetylsalicylic acid or non-steroidalanti-inflammatory drugs not discontinued before surgery
hemoglobin (HB) concentration <10 mg/dl _allergy to TXA.
BMI > 35 kg/ m2
Study Design
Study Description
Connect with a study center
Main building, Assiut University Hospitals
Assiut,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.